Table 2.

Summary of patients on low dose (< 4 mg/kg/day) disulfiram (n = 34).

Patient ID	M/F	Age	Weight (kg)	Max Dose (mg/kg/day)	Duration	Infection & Other Conditions	Other Rx	Adverse Reaction	Benefit
14 1	M	61	76	1.6	3 MO	Bb, Bm, MND		LFT	Y: constitution N: neurologic
25	F	17	59	2.1	3 MO	Bb		LFT, Psych	Y
26	M	71	85	2.9	2 MO	Bb, TBRF, MSA-C		Psych	N
27	F	60	64	2	4 MO	Bb		FAT	Y
28	F	52	64	2.9	4 MO	Bb, MCAS			Y
30	M	34	79	3.1	4 MO	Bb, Bh			Y
31	M	36	61	0.3	4 MO	Bb		FAT	Y
32	M	20	66	0.5	6 MO	Bb			unclear
33	F	55	57	0.9	7 MO	Bb, Bh			Y
35	M	64	68	0.6 0.6	5 MO 4 WK	Bb, TBRF			Y, marginal
40	F	58	50	1.3	4 MO+	Bb			Y
41	M	21	91	0.9	8 WK	Bb, Bh			unclear
43	F	20	48	0.3	6 MO+	Bb		FAT, Arth	Y
44	F	57	70	0.6	3 MO+	Bb		FAT	Y
45	F	72	106	0.6	5 MO+	Bb		FAT	Y
46	M	17	159	1.5	8 MO+	Bb, Bd		FAT, LFT	Y
47	F	19	104	0.1	3 MO+	Bb			Y
48	F	64	66	0.9 0.9	4 MO 3 MO+	Bb, Bh		FAT, LFT	Y Y
51	M	83	99	1.1	4 MO+	Bb, OBS		FAT	Y
52	F	64	68	0.5	2 MO+	Bb			Y
53	F	23	95	1.6	7 MO	Bb, Bh		PN, Arth	Y
55	M	17	84	1.5	2 MO+	Bb, Bh	azith, rifam		Y
56	M	39	83	0.2	5 MO+	Bb		FAT, Psych	Y
57	M	61	80	0.1	1 MO+	Bb, NMD			Y
58	M	19	86	0.2	6 MO+	Bb		FAT, LFT	Y
59	M	79	120	0.3	11 MO+	Bb, MG-like NMD	pyridosti- gmine		Y
60	F	18	54	0.8	3 MO+	Bb, Bd, TBRF			Y
61	M	30	73	3.4	5 MO+	Bb			Y
62	F	51	43	1	16 MO+	Bb, Bm			Y
63	M	69	113	0.6	2 MO+	Bb		Psych	Y
64	M	59	105	1.2	2 MO+	Bb			Y
65	F	43	49	2.5 0.4	4 MO 4 MO+	Bb, Bm, Bh		FAT, Psych	Y Y
66	F	18	57	0.3	2 MO+	Bb	clarithro		Y
67	M	39	80	3	6 WK	Bb			Y

¹ Patient deceased from MND.